SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amanta Healthcare - Quaterly Results

20 May 2026 Evaluate
The revenue for the March 2026 quarter is pegged at Rs. 769.95 millions, about 6.84% up against Rs. 720.63 millions recorded during the year-ago period.The Net Profit of the company registered a slight decline of -7.18% to Rs. 55.32  millions from Rs. 59.60 millions.A decline of 166.15 millions was observed in the OP in the quarter ended March 2026 from 191.26 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 769.95 720.63 6.84 2876.77 2747.08 4.72 2876.77 2747.08 4.72
Other Income 16.62 1.62 925.93 33.71 13.85 143.39 33.71 13.85 143.39
PBIDT 166.15 191.26 -13.13 632.28 610.53 3.56 632.28 610.53 3.56
Interest 42.46 62.81 -32.40 207.46 279.48 -25.77 207.46 279.48 -25.77
PBDT 123.69 128.45 -3.71 398.53 331.05 20.38 398.53 331.05 20.38
Depreciation 47.52 46.94 1.24 187.30 183.99 1.80 187.30 183.99 1.80
PBT 76.17 81.51 -6.55 211.23 147.06 43.64 211.23 147.06 43.64
TAX 20.85 21.91 -4.84 62.49 42.06 48.57 62.49 42.06 48.57
Deferred Tax -8.45 3.76 -324.73 -23.40 6.14 -481.11 -23.40 6.14 -481.11
PAT 55.32 59.60 -7.18 148.74 105.00 41.66 148.74 105.00 41.66
Equity 343.36 282.70 21.46 343.36 282.70 21.46 343.36 282.70 21.46
PBIDTM(%) 21.58 26.54 -18.69 21.98 22.22 -1.11 21.98 22.22 -1.11

Amanta Healthcare Share Price

156.45 -6.05 (-3.72%)
03-Jul-2026 14:38 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.00
Dr. Reddys Labs. 1371.00
Cipla 1457.15
Zydus Lifesciences 1134.05
Lupin 2467.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: